Differences between CAT and mMRC in Patients with COPD
분야
의약학 > 내과학
저자
이진국 , 조재화 , 김태형 , 이상학 , 이진화 , 김영삼 , 정지예 , 박용범 , 신경철 , 윤형규 , 이상엽 , 민경훈 , 유광하 , 정기석
발행기관
대한결핵 및 호흡기학회
간행물정보
대한결핵및호흡기학회 추계학술발표초록집 2012년, 제114권 226(총1페이지)
파일형식
0y909955.pdf [무료 PDF 뷰어 다운로드]
  • ※ 본 자료는 참고용 논문으로 수정 및 텍스트 복사가 되지 않습니다.
  • 구매가격
    1,000원
    적립금
    30원 (구매자료 3% 적립)
    이메일 발송  스크랩 하기
    자료 다운로드  네이버 로그인
    영문초록
    Background: The 2011 GOLD consensus uses symptoms to categorise patients according to disease severity and guide treatment. COPD Assessment Test (CAT) and modified Medical Research Council (mMRC) are both used to evaluate the symptoms. Purpose: To examine the discripancy between CAT and mMRC in patients with COPD. Methods: Patients were recruited from 49 centres in Korea, as part of the COPD cohort (KOCOSS) study. Results: Total 223 patients with COPD were eligible for analysis. Age was 68.0±7.6 (Mean±SD) and 88.3% were male. FVC, FEV1, and FEV1/FVC were 3.08±0.84 L (83.24±19.00%), 1.42±0.56 L (51.98±17.12%), and 45.88±11.52%. Mean CAT score was 16.27±8.36. There was sigificant correlation between CAT and mMRC (R=0.516, P<0.001). However, mMRC was less than 2 in 60.0% of patients while CAT was less than 10 in only 21.2% of patients. Discripancy between mMRC and CAT were observed in 45.9% of patients. Conclusion: Although there was correlation between CAT and mMRC, discripancy between two scores was noted. Further study regarding CAT and mMRC in patients with COPD is needed.
    사업자등록번호 220-87-87785 대표.신현웅 주소.서울시 서초구 방배로10길 18, 402호 대표전화.070-8809-9397
    개인정보책임자.박정아 통신판매업신고번호 제2017-서울서초-1765호 이메일 help@reportshop.co.kr
    copyright (c) 2009 happynlife. steel All reserved.